Private Investment Firm

L1 Health

Investment Details

Investor Type
Private Investment Firm

Asset Class Focus
Private Equity, Venture Capital

Stage Focus
Early Stage, Growth, Late Stage

Geographical Focus
United States, United Kingdom, Canada, Germany, Japan, Australia, China, India, Brazil, France, Italy, United Arab Emirates, Spain, Mexico, South Korea, Saudi Arabia, Turkey, Netherlands, South Africa, Russia

Industries Focus

  • Healthcare
  • Healthcare Services
  • Digital Health
  • Pharmaceuticals
  • Medical Devices
  • Diagnostics
  • Biotechnology
  • Health and Wellness
  • Medical Research
  • Consumer Health
  • Medical Equipment
  • Health Insurance
  • Healthcare IT
  • Healthcare Infrastructure
  • Medical Supplies

Investment Size:
50,000,000 to 1,000,000,000 USD

Investor Details Founded: 2016

L1 Health is an international investment firm focusing on the healthcare sector. It is a subsidiary of LetterOne Holdings S.A., a Luxembourg-based investment company established in 2013. L1 Health was launched in 2016 with the goal of investing up to $2-3 billion in the global healthcare sector over the next three years. The firm aims to make substantial equity investments in businesses that it can support and help grow over significant periods of time. L1 Health's investment strategy is driven by factors such as aging populations, rising healthcare costs, and technological innovations in the healthcare industry. The firm seeks to leverage insights gained from its healthcare investments in private equity to build expertise and invest at scale. L1 Health's portfolio includes investments in various healthcare sectors, including pharmaceuticals, biotechnology, medical devices, and healthcare services. The firm is committed to supporting the growth and development of its portfolio companies, aiming to create value through long-term partnerships and strategic guidance. L1 Health's approach combines financial investment with operational support, leveraging the broader resources and expertise of the LetterOne group to drive success in the healthcare sector. The firm's investment philosophy emphasizes a patient and strategic approach, focusing on building strong foundations for sustainable growth and value creation in the healthcare industry.

L1 Health's leadership includes experienced professionals with extensive backgrounds in the healthcare and investment sectors. The firm's advisory board features individuals with significant expertise in pharmaceuticals and healthcare, contributing to its strategic direction and investment decisions. L1 Health's commitment to the healthcare sector is reflected in its substantial investment activities and its focus on addressing key challenges and opportunities within the industry. The firm's investments are guided by a deep understanding of the healthcare landscape, aiming to make a positive impact on global health through strategic and thoughtful investments. L1 Health's operations are supported by the broader LetterOne group, which provides financial strength and a global network to enhance the firm's investment capabilities. The firm's strategic initiatives are designed to align with the evolving needs of the healthcare sector, positioning L1 Health as a significant player in global healthcare investments.

L1 Health's investment approach is characterized by a focus on long-term value creation, operational excellence, and a commitment to improving healthcare outcomes. The firm's portfolio reflects a diverse range of healthcare investments, each selected for its potential to contribute to the advancement of global health. L1 Health's strategic investments are aimed at fostering innovation, improving patient care, and addressing critical healthcare challenges worldwide. The firm's dedication to the healthcare sector is evident in its proactive engagement with portfolio companies, providing them with the resources and support needed to achieve sustainable growth and success. L1 Health's role within the LetterOne group underscores its importance in the firm's overall investment strategy, contributing to the group's mission of creating value through strategic investments in key sectors. The firm's ongoing efforts are focused on identifying and capitalizing on opportunities that align with its vision for the future of healthcare.

L1 Health's impact on the healthcare industry is measured by the success and growth of its portfolio companies, the advancement of healthcare solutions, and the positive changes it brings to global health. The firm's strategic investments are designed to address pressing healthcare needs, promote innovation, and enhance the quality of care provided to patients worldwide. L1 Health's commitment to excellence and its strategic vision continue to drive its success in the dynamic and evolving healthcare investment landscape.

Requirements
  • Established healthcare companies with strong growth potential
  • Innovative healthcare startups with scalable business models
  • Businesses operating in sectors such as pharmaceuticals, biotechnology, medical devices, and healthcare services
  • Companies seeking long-term investment partnerships and strategic support
Contact

[Official Website Hidden]

[Email Hidden]

[Contact Number Hidden]

Portfolio Companies
  • Allergan
  • Actavis
  • Bausch + Lomb
  • Daiichi Sankyo
  • Dr. Reddy's Laboratories
  • Fresenius Medical Care
  • Gilead Sciences
  • GlaxoSmithKline
  • Hikma Pharmaceuticals
  • Ipsen
  • Jazz Pharmaceuticals
  • Mylan
  • Novartis
  • Pfizer
  • Sanofi
  • Shire
  • Teva Pharmaceutical Industries
  • Valeant Pharmaceuticals
  • Zynerba Pharmaceuticals
Claim this Investor

Are you an official representative of L1 Health?

Claim this investor to update information, manage your profile, and get a verified seal.

Claim